QA: ENZO BIOCHEM INC in us_health_services/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000316253_2020_ENZO_BIOCHEM_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000316253, ENZO BIOCHEM INC

  xvar xval
0 IntangibleAssets 8,484,000
1 AssetsNonCurrent 2,449,000
2 AssetsCurrent 81,453,000
3 PropertyPlantAndEquipment 14,254,000
4 remainder_Assets 0
5 LongTermLiabilities 4,603,000
6 LiabilitiesCurrent 16,009,000
7 remainder_Liabilities 0
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 57,922,000
10 GeneralAndAdministrativeExpense 44,265,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 3,175,000
16 remainder_Expenses -25,925,000
17 remainder_Revenues 81,170,000
18 remainder_NetIncome 756,000
19 remainder_ComprehensiveNetIncome 480,000
  yvar yval
0 Assets 106,640,000
1 Liabilities 20,612,000
2 Expenses 79,437,000
3 Revenues 81,170,000
4 StockholdersEquity 86,028,000
5 NetIncome 2,489,000
6 ComprehensiveNetIncome 2,969,000
7 BaseVar 171,251,595
8 EconomicCapitalRatio 2.35

Edgar->Model Mapping

Feature Distribution

Change over Time